Karasev, S.M.,
Sufianov, A.A.,
Khafizov, R.R.,
Karaseva, I.I.,
Shugushev, Z.K.,
Maximkin, D.A.,
Khafizov, T.N. (2021) and cosmetic consequences. Existing treatment options include surgical resection, endovascular
embolizationTCTAP C-025
EMBOLIC MYOCARDIAL INFARCTION CAUSED BY LEFT ATRIUM EMBOLI FROM ATRIAL FIBRILLATION
ATAS, A.E.,
SARAC, A.,
DIRICAN, A.,
TOPBASI, N.,
UZAR, T.,
RASTGAR, L.,
PANKINA, E.,
OZKAYA, S. (2019) Background: Mortality rates due to massive pulmonary
embolism (PE) are much higher than
estimated
KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) Renal cell carcinoma (RCC) is a common
renal neoplasia of various morphological types, among which
Gilyazova, I.,
Ivanova, E.,
Gilyazova, G.,
Sultanov, I.,
Izmailov, A.,
Safullin, R.,
Pavlov, V.,
Khusnutdinova, E. (2021) Background
Renal cell carcinoma is the most common form of kidney cancer in adults. DNA methylation
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) risk of developing disease outcomes from the general population. Clear cell
renal cell carcinoma (cc
GILYAZOVA, I.R.,
KLIMENTOVA, E.A.,
BERMISHEVA, M.A.,
KHUSNUTDINOVA, E.K.,
IZMAILOV, A.A.,
GALIMOVA, E.F.,
SAFIULLIN, R.I.,
GALIMOV, S.N.,
V.N. Pavlov,
BULYGIN, K.V. (2020) in patients with metastatic clear cell
renal cell carcinoma (ccRCC). Analysis of microRNA expression